Posting date:
03/07/2018
Following Proclinical’s
recent office opening in China, it’s onwards and upwards for the life science staffing
and consultancy group as they open for business in yet another new territory, San
Francisco. The expansion is part of the company’s vision to provide superior
workforce solutions by growing their capabilities and extending their reach to
become a pan-USA staffing resources provider.
In early
May 2018, Proclinical made its first endeavour into the West Coast by
establishing a base in San Francisco, a hotbed of biotech, biopharma and health
technology innovation. Having established itself rapidly on the East Coast over
the past two years with hugely successful recruitment teams in New York and
Philadelphia, Proclinical looks to tap into another of the USA’s vibrant life
science hubs.
Much of
California’s innovation is concentrated in the Bay Area, home to cutting-edge
biotech and health technology companies leading the way in areas such as
cancer, infectious diseases and immune disorders – some of the biggest health
threats we face today. Offering around 900,000 jobs in over 3,200 life science
companies, California is teeming with talent and opportunity that Proclinical
is keen to discover.
Proclinical’s CEO Daniel Smart explains the driving force behind the company’s move to the West, “Proclinical
is delighted to not only expand regionally, but also functionally. San
Francisco is home to a thriving cluster of trailblazing health technology companies,
and establishing a base here will help us penetrate this exciting market. Our
team in San Francisco is set to hit the ground running, with the aim of extending
our current medical device recruitment offering to life science clients in this
area.”
Proclinical hopes to further extend its presence along
the West Coast with eventual plans to move into San Diego and Seattle.
About Proclinical
Proclinical is
a leading global staffing services and consulting provider that specialises
exclusively within the life sciences industry. Our client base includes leading
global pharmaceutical companies, biopharmaceutical companies, biotechs, medical
device pioneers, and associated life science companies, including CROs and the
outsourcing sector.
.png)
.png)
